Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer
多西他赛联合环氧合酶-2抑制剂塞来昔布治疗老年或体能状态较差(PS2)的晚期非小细胞肺癌患者的II期研究
期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e31818b194e
Gadgeel, Shirish M; Wozniak, Antoinette; Ruckdeschel, John C; Heilbrun, Lance K; Venkatramanamoorthy, Raghu; Chaplen, Ruth A; Kraut, Michael J; Kalemkerian, Gregory P